Scroll To Top
Search by Speciality

10th European Breast Cancer Conference

RAI Amsterdam * | Amsterdam, NETHERLANDS
From 250 to 875 EUR
Event Preview
This event
is Finished
Title: 10th European Breast Cancer Conference
Specialty: Radiation Oncology
Dates: From Mar, 9, 2016 to Mar, 11, 2016
Location: Amsterdam, NETHERLANDS
Type: Conference
Registration Cost: From 250 to 875 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Amsterdam, Netherlands.
General Info
Event Venue:

RAI Amsterdam *

Amsterdam, NETHERLANDS Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

The European Breast Cancer Conference in 2016 (EBCC-10) will take place in the context of very tangible advances that have been made for patients in recent years. These advances have been largely achieved through the successful application of a multidisciplinary approach in the treatment and care of breast cancer. 

EBCC is proud to have played its role in driving these advances for breast cancer patients as a unique, dedicated multidisciplinary platform and the largest breast cancer conference outside the US.  

This edition of EBCC (EBCC-10) is again firmly based on a holistic vision of breast cancer and brings together scientists, clinicians, patient representatives and health professionals of diverse profiles to tackle key issues facing patients throughout the continuum of the breast cancer journey. The conference programme will provide the latest insights into the areas of prevention, optimal diagnosis, treatment, survivorship, the advance driven by research in all of them so that EBCC again fulfills its mission to accelerate the translation of clinical research into best practice made widely available to patients all over Europe. 

EBCC-10 will replicate the highly successful “Multidisciplinary Teams in the Real World” and will have a strong focus on the work of the breast team throughout its programme. Our aim is to strengthen the knowledge of different members of the breast team as well as help ensure the optimal work of the team as a whole. The conference registration fee structure has been designed specifically to support the participation of breast teams. 

The conference will again showcase practice-changing new data and provide delegates with the opportunity to discuss it in sessions with innovative, interactive formats. 

EBCC-10 will highlight important regulatory developments in Europe. A European Parliament resolution has stipulated that by 2016 member states should have enshrined in law that all breast cancer patients are to be treated in a specialised breast centre or unit. At EBCC-10, we will review the impact this resolution has had so far on the treatment of breast cancer, we will map the status of its implementation and discuss how best to direct our advocacy efforts in 2016 and beyond. 

We look forward to welcoming you to Amsterdam on 9 – 11 March 2016: EBCC-10 awaits your active participation. Help us make it our best ever conference!

Fatima Cardoso


Roswitha Britz


Emiel Rutgers


Conference ChairConference Co-Chair

National Organising

Committee Chair

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2015-10-10 To: 2016-01-25
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Amsterdam RAI Hotel & Travel Service (RHTS) is part of RAI Amsterdam B.V. and arranges hotel accommodation for many international conferences in Amsterdam. Amsterdam RAI Hotel & Travel. Service has been appointed as the official accommodation agent for the European Breast Cancer Conference 2016 in Amsterdam from March 9 - 11, 2016.

Amsterdam RAI Hotel & Travel Service

PO Box 77777

NL - 1070 MS Amsterdam

Phone: +31 (0)20 549 1927

Fax: +31 (0)20 549 1946


Selection of Hotels

In close consultation with the organization of the European Breast Cancer Conference, Amsterdam RAI Hotel & Travel Service made a wide selection of hotels in Amsterdam for you in the different categories (3- to 5-star). Amsterdam RAI Hotel & Travel Service offers hotels near the Amsterdam RAI, as well as in the historical city centre of Amsterdam. As the demand for hotel rooms will be high during the European Breast Cancer Conference 2016, Amsterdam RAI Hotel & Travel Service has contracted a large amount of rooms. Nevertheless, we suggest that you reserve your hotel room as soon as you know your exact travel dates.

Hotel website for online bookings

Amsterdam RAI Hotel & Travel Service has created a secured hotel website for European Breast Cancer Conference 2016. On this website you can read a comprehensive description of each hotel, including photos, a map of Amsterdam and ‘How to come to the Amsterdam RAI’ and you can book your hotel room online and receive a direct confirmation.

Individual reservations (maximum 9 rooms)

Individual reservations for up to 9 rooms can be made through the fully secured hotel website. A direct confirmation will be sent by email. All individual reservations require a guarantee with a valid credit card. The payment of your stay will be settled in the hotel. Notifications of cancellations and changes can be made online or by emailing the Amsterdam RAI Hotel & Travel Service. Accordingly, an administration fee of EUR 15 per room will be charged. However, if annulment is received within 48 hours prior to the arrival date, the hotel is entitled to charge according to the cancellation policy.

Scientific Content Up to Date
Submission Info

Abstract submission open: 15 August 2015

Abstract submission deadline: 4 November 2015, 21:00 Central European Time

Abstracts submitted after the stipulated deadline will not be considered. 

Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.

In case of any abstract related queries please contact:


Abstract Policy and Regulations

Abstracts on case studies will be rejected.

With the submission of an abstract to 10th European Breast Cancer Conference (EBCC-10), the presenting author:

Certifies to be an investigator with substantial involvement in the clinical study presented in the abstract.

Accepts responsibility for the accuracy of the submitted abstract.

Accepts to be the contact person for all correspondence regarding the abstract and inform co-authors of its status.

Confirms that all co-authors are aware of and agree to the content of the abstract and support the data presented.

Warrants that the data and conclusions presented in the abstract have not been presented or published at any meeting of 500 delegates or more prior to the EBCC-10 conference.

Agrees to submit updated data for important large studies presented (in part) at previous meetings. Violation of this policy may result in rejection of the submitted abstract.

Certifies that the information in the abstract is for exclusive presentation in the European Breast Cancer Conference Scientific Programme and will not be presented during the EBCC-10 at any Satellite Symposia.

States that for all studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and informed consent given where appropriate.

For abstracts containing clinical trial data include: Trial abbreviation; Trial Registry Number or ID background; Objective, Design, Population studied (including sample size), Intervention, Outcome measure (s), Analysis, Trial status, Trial sponsor(s)

Identifies, obtains and discloses any financial interest in products or processes described in the abstract for all abstract authors. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research and other substantive relationships. 

Releases the copyright on behalf of all authors, to ECCO and gives permission for the abstract, when selected for presentation, to be published in the European Breast Cancer Conference Abstract book - a European Journal of Cancer Supplement (in electronic format), as well as on the EBCC-10 website.

Trials in Progress abstracts will not be accepted.


Abstract Preparation and Submission

Abstracts must be submitted in good English and carefully proofread to ensure the accuracy of published material. The Scientific Committee reserves the right to reject abstracts submitted in poor English, or may request an immediate revision by the author.

Authors may provide their preference of presentation format: oral, poster or no preference.

Please choose one main topic to categorise. 

The Scientific Committee has the authority to re-categorise the abstract.

The title of the abstract should be concise and accurately describe the study undertaken. Do not use non-standard abbreviations and commercial names (generic names only).

Abstracts should be structured to include the following 4 sections:

Background: introductory sentence specifying the purpose of the study

Material and methods: brief description of relevant experimental procedures

Results: summary of the results of the investigation

Conclusions: a statement of the main conclusions

The abstract submission system will not accept abstracts that exceed 2900 characters (including body of the abstract, spaces and one table).

Only one data table is permitted in the body of the abstract. Illustrations and figures are not allowed and will be deleted if submitted.

Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase).  Compounds should be mentioned with the generic name, in lower cases.  Commercial names are admitted in the text, with an ®, and if in brackets following the generic name, i.e. “generic (Commercial ®)”. 

No more than 20 authors can be listed with only their institutional affiliation(s), city and country. Mailing addresses and academic degrees should not be mentioned. For co-operative study groups, the name of the group should be used instead of individual institutional affiliations or include the name of the group in the title of the abstract.

An e-mail confirming receipt of the abstract submitted online will be sent to the presenting author within 48 hours. An abstract number will be allocated and should be mentioned for any queries relating to the submitted abstract.


Abstract Selection Process

Abstracts submitted for presentation in the EBCC-10 will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted. The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee.

The following presentation formats are applicable at the EBCC-10:


Oral presentation

The abstract is selected for oral presentation in one of the proffered papers sessions. Abstracts of superior quality can be selected for presentation in a session where discussants will place the research findings into perspective.

Poster Presentation 

Abstracts that have been selected for poster presentation will be displayed on poster boards in a prominent poster viewing area next to the exhibition.  The posters will be grouped by topic and displayed for four hours each.  A specific time will be devoted to poster viewing to ensure delegates have sufficient opportunity to acquaint themselves with the presented data.

Poster Discussion 

Prominent experts will provide a thematic overview and discuss the findings from selected abstracts chosen for poster presentation. Delegates will be offered an expert review-at-a-glance of the presented findings and will be able to further refine their interest in specific abstracts.

Poster Spotlight Sessions 

The Scientific Committee will make a special selection of posters which will be highlighted through short oral presentations followed by moderated discussion. These sessions will facilitate dynamic exchange on selected findings of broad interest.


Submitting an abstract for presentation in the EBCC-10 does not constitute registration for the conference. When selected, abstract presenters must register to attend the European Breast Cancer Conference in Amsterdam

The presenting author will receive a letter with the result of the review and the Scientific Committee’s decision on the abstract by mid December 2015.

Abstract Withdrawal

ECCO cannot guarantee any request for withdrawal of an abstract that in any way delays the publications. Requests to withdraw abstracts will be accepted until 21 December 2015. After this date, abstracts selected for presentation must be presented. If the presenting author of a selected abstract cannot attend, they should assign a replacement and inform EBCC secretariat of the replacement as soon as possible.

Sponsors Exhibitors
General Info

The European Breast Cancer Conferences are the responsibility of the not-for-profit association European Breast Cancer Council (EBC Council). The European Breast Cancer Council (EBC Council) is an association of European organisations involved in breast cancer.  The three founding members of the organisation are EORTC Breast group, EUSOMA and EUROPA DONNA. The mission of the Association is to raise awareness and improve prevention, diagnosis, treatment and care of breast cancer patients.


Founding members

EUROPA DONNA – The European Breast Cancer Coalition is an independent, nonprofit organisation whose members are affiliated groups from throughout Europe. The coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and care and increased funding for research. EUROPA DONNA represents the interests of European women regarding breast cancer to local and national authorities as well as to institutions of the European Union.  For additional information on EUROPA DONNA please


The EORTC Breast Cancer Group is a multidisciplinary group of clinical researchers and scientists involved in the development, coordination and implementation of clinical and translational research, endeavouring to improve treatment of breast cancer patients in Europe and beyond. The EORTC BCG has led and/or supported studies that have changed clinical practice in the management of breast cancer, including breast conservation, treatment of DCIS, management of the lymph nodes, neo adjuvant chemotherapy etc..  For additional information on the EORTC Breast Cancer Group please visit:


The European Society of Breast Cancer Specialists (EUSOMA) is a non-profit organisation that promotes the multidisciplinary approach to breast cancer diagnosis and treatment. Its members are specialists from across the spectrum of professions involved in breast care. EUSOMA is committed to promoting interaction between all the health professionals involved in breast cancer care with the aim of ensuring that all patients with breast problems have equitable access to high quality care delivered by specialist breast teams. EUSOMA is directly involved in setting evidence based standards that form the basis for certification and accreditation of breast centres and the clinical care that they provide.

EUSOMA achieves this by organising and participating in workshops and other scientific meetings that consider current evidence that forms the basis for setting standards for early detection, diagnosis, treatment and after care. In these meetings European experts are invited in the different disciplines dedicated to Breast Cancer. These guidelines and recommendations are disseminated throughout Europe. The EUSOMA guidelines ‘The requirements of a specialist breast centre’ are recognised as the current reference document on the definition of breast centres and form the basis for Breast Centre Certification

Organising Agency

ECCO Contact Information


ECCO - the European CanCer Organisation

Avenue E. Mounier 83 

B-1200 Brussels, Belgium 

Tel: +32 2 775 02 01 

Fax:+32 2 775 02 00

Event map
Revelant Events